Single-cell Focus Capitalize on Samplix's core Xdrop single-cell analysis technology for immunotherapy and engineered cell therapy research to target biotech buyers seeking high-resolution cell activity insights and faster screening.

High-Throughput Leap Position Xdrop Sort and microfluidic-based screening as a solution for high-throughput gene and cell screening workflows, appealing to labs looking to scale experiments beyond traditional methods.

Accelerated Timelines Emphasize the limited-volume droplets that accelerate interaction detection and reduce screening times, targeting speed-focused R&D teams and contract research organizations.

Service & Access Leverage Samplix’s historical expansion into comprehensive service programs and CRISPR validation offerings to upsell full-service or access-based models to research facilities seeking turnkey capabilities.

Strategic Partnerships Highlight potential collaborations with established players in gene editing and synthetic biology to expand market reach, drawing on past partnerships and funding-friendly growth signals.